| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Endocrinology (R.B., M.L.-Z., G.J.), Sahlgrenska University Hospital, SE-413 45 Gothenburg, Sweden; and Department of Mathematical Sciences (A.O.), Chalmers University of Technology, SE-412 96 Gothenburg, Sweden
Address all correspondence and requests for reprints to: Ragnhildur Bergthorsdottir, M.D., Department of Endocrinology, gr str 8, Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden. E-mail: Ragnhildur.Bergthorsdottir{at}medic.gu.se.
Background: The survival rate of patients with primary adrenal insufficiency (Addison’s disease) undergoing currently accepted replacement therapy is not known, although well-informed patients are considered to have a normal survival rate. In this study, we evaluated the mortality of patients with Addison’s disease in Sweden.
Methods: A population-based, retrospective, observational study was performed, using the National Swedish Hospital and Cause of Death Registers, covering the period from 1987–2001. After a diagnosis of Addison’s disease, each patient was followed until the end of follow-up or death. Mortality was compared with that of the Swedish background population.
Findings: We identified 1675 patients (995 women and 680 men) diagnosed with primary adrenal insufficiency. The average follow-up from initial diagnosis was 6.5 yr. Five hundred seven patients died during the study period compared with an expected 199. The risk ratio for all-cause mortality was 2.19 (confidence interval 1.91–2.51) for men and 2.86 (confidence interval 2.54–3.20) for women. The excess mortality in both men and women was attributed to cardiovascular, malignant, and infectious diseases. Concomitant diabetes mellitus was observed in 12% of the patients, but only contributed to the increased mortality to a minor extent.
Interpretation: Compared with the background population, we observed that the risk ratio for death was more than 2-fold higher in patients with Addison’s disease. Cardiovascular, malignant, and infectious diseases were responsible for the higher mortality rate.
This article has been cited by other articles:
 |
|
 |
|
  H. Filipsson and G. Johannsson GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies Eur. J. Endocrinol., November 1, 2009; 161(S1): S85 - S95. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sherlock, R. C. Reulen, A. A. Alonso, J. Ayuk, R. N. Clayton, M. C. Sheppard, M. M. Hawkins, A. S. Bates, and P. M. Stewart ACTH Deficiency, Higher Doses of Hydrocortisone Replacement, and Radiotherapy Are Independent Predictors of Mortality in Patients with Acromegaly J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4216 - 4223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Leelarathna, J.K. Powrie, and P.V. Carroll Thomas Addison's disease after 154 years: modern diagnostic perspectives on an old condition QJM, August 1, 2009; 102(8): 569 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Johannsson, R. Bergthorsdottir, A. G Nilsson, H. Lennernas, T. Hedner, and S. Skrtic Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study Eur. J. Endocrinol., July 1, 2009; 161(1): 119 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. L. Rice, N. Agarwal, H. Bolusani, R. Newcombe, M. F. Scanlon, M. Ludgate, and D. A. Rees Effects of Dehydroepiandrosterone Replacement on Vascular Function in Primary and Secondary Adrenal Insufficiency: A Randomized Crossover Trial J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 1966 - 1972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Debono, R. J Ross, and J. Newell-Price Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy Eur. J. Endocrinol., May 1, 2009; 160(5): 719 - 729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Debono, C. Ghobadi, A. Rostami-Hodjegan, H. Huatan, M. J. Campbell, J. Newell-Price, K. Darzy, D. P. Merke, W. Arlt, and R. J. Ross Modified-Release Hydrocortisone to Provide Circadian Cortisol Profiles J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1548 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Arlt The Approach to the Adult with Newly Diagnosed Adrenal Insufficiency J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1059 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M Erichsen, K. Lovas, K. J Fougner, J. Svartberg, E. R Hauge, J. Bollerslev, J. P Berg, B. Mella, and E. S Husebye Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death Eur. J. Endocrinol., February 1, 2009; 160(2): 233 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bleicken, S. Hahner, M. Loeffler, M. Ventz, B. Allolio, and M. Quinkler Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens Eur. J. Endocrinol., December 1, 2008; 159(6): 811 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R Walker Glucocorticoids and Cardiovascular Disease Eur. J. Endocrinol., November 1, 2007; 157(5): 545 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hahner, M. Loeffler, M. Fassnacht, D. Weismann, A.-C. Koschker, M. Quinkler, O. Decker, W. Arlt, and B. Allolio Impaired Subjective Health Status in 256 Patients with Adrenal Insufficiency on Standard Therapy Based on Cross-Sectional Analysis J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3912 - 3922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Elfstrom, S. M. Montgomery, O. Kampe, A. Ekbom, and J. F. Ludvigsson Risk of Primary Adrenal Insufficiency in Patients with Celiac Disease J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3595 - 3598. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
